Latest Avandia news
CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with type 2 diabetes, according to a study published online June 6 in Diabetes Care.
Addition of Glitazone to Chemo May Help Treat CML
posted September 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.
Editor's Recommendations
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma 
Hematologic Cancer Survivors Face Higher Risk of Developing Cardiovascular Disease 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
